Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 110Carcinoma, Intraductal, Noninfiltrating 7Breast Carcinoma In Situ 6Neoplasms 4Neoplasm Metastasis 3Inflammatory Breast Neoplasms 3Carcinoma, Ductal, Breast 3Breast Neoplasms, Male 3Infertility 2Fallopian Tube Neoplasms 2Endometrial Neoplasms 2Breast Cancer Female 2Sleep Wake Disorders 1Quality of Life 1Pulmonary Fibrosis 1Prostatic Neoplasms 1Primary Breast Cancer 1Polycystic Ovary Syndrome 1Paget's Disease, Mammary 1Ovarian Neoplasms 1Obesity 1Neoplasm Recurrence, Local 1Liver Neoplasms 1Hot Flashes 1Fatigue 1Cardiotoxicity 1Carcinoma, Ovarian Epithelial 1Carcinoma, Lobular 1Carcinoma, Hepatocellular 1Breast Cancer Subjects 1

Interventions

Gabapentin 3liposomal amphotericin B 2oxybutynin 1fezolinetant 1black cohosh root extract 1Venlafaxine Hydrochloride 1Vancomycin 1Testosterone 1Tazobactam 1Tamoxifen 1Tablets 1Sugars 1Soybean Proteins 1Pregabalin 1Piperacillin, Tazobactam Drug Combination 1Piperacillin 1Mind-Body Therapies 1Megestrol Acetate 1Medroxyprogesterone 1Linseed Oil 1Levofloxacin 1Isoflavones 1Hypnosis 1Goserelin 1Folic Acid 1Filgrastim 1Estrogens, Conjugated (USP) 1Estradiol 1Cyproterone Acetate 1Citalopram 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Hot Flashes × Tamoxifen × Clear all
NCT06440967 2026-04-06

A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Therapy

Astellas Pharma Inc

Phase 3 Active not recruiting
984 enrolled

Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡